Edition:
United States

Aurinia Pharmaceuticals Inc (AUP.TO)

AUP.TO on Toronto Stock Exchange

6.97CAD
14 Aug 2018
Change (% chg)

-- (--)
Prev Close
$6.97
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,821
52-wk High
$9.50
52-wk Low
$5.68

Chart for

About

Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in particular lupus nephritis (LN). It is focused on the development of its lead... (more)

Overall

Beta: 3.44
Market Cap(Mil.): $581.16
Shares Outstanding(Mil.): 84.48
Dividend: --
Yield (%): --

Financials

  AUP.TO Industry Sector
P/E (TTM): -- 169.61 31.56
EPS (TTM): -0.74 -- --
ROI: -25.96 1.42 12.88
ROE: -29.71 0.52 15.04

BRIEF-Aurinia Reports Qtrly Loss Per Share $0.18

* AURINIA REPORTS FIRST QUARTER FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

May 10 2018

BRIEF-Aurinia Pharmaceuticals Reports Qtrly Loss Per Share ‍of $0.04​

* AURINIA REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Mar 15 2018

Earnings vs. Estimates